Intensive Care Therapy of Covid-19 Disease in Germany

NCT ID: NCT04455451

Last Updated: 2022-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2054 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-06

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multi-center retrospective and prospective observational study of Covid-19 patients with severe or critical illness treated on a German ICU

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID ARDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age above 18 years
* Covid-19 disease (positive SARS-CoV-2 PCR)

Exclusion Criteria

-none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Tuebingen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Rosenberger, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tübingen

Harry Magunia, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tübingen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RWTH Aachen - Department for operative Intensive Care Medicine and intermediate Care

Aachen, , Germany

Site Status

Zollernalbklinikum

Balingen, , Germany

Site Status

Charité Universitätsmedizin Berlin

Berlin, , Germany

Site Status

UH Bochum - Department for Anesthesiology and Intensive Care Medicine

Bochum, , Germany

Site Status

Universitätsklinikum Bonn

Bonn, , Germany

Site Status

Klinikum der Universität Witten/Herdecke - Köln / Klinik für Anästhesiologie und operative Intensivmedizin

Cologne, , Germany

Site Status

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, , Germany

Site Status

Ev. Krankenhaus Bethesda Duisburg Klinik für Anästhesiologie und Intensivmedizin

Duisburg, , Germany

Site Status

Univerrsitätsklinikum Düsseldorf

Düsseldorf, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Universitätsklinikum Frankfurt

Frankfurt, , Germany

Site Status

University Hospital Freiburg - Department for Anesthesiology and Intensive Care Medicine

Freiburg im Breisgau, , Germany

Site Status

Universitätsklinikum Giessen Klinik für Anaesthesiologie und operative Intensivmedizin

Giessen, , Germany

Site Status

Universitätsmedizin Göttingen Klinik für Anästhesiologie

Göttingen, , Germany

Site Status

Universitätsklinikum Greifswald

Greifswald, , Germany

Site Status

Universitätsklinikum Halle

Halle, , Germany

Site Status

University Hospital Heidelberg - Department for Anesthesiologie and Intensive Care Medicine

Heidelberg, , Germany

Site Status

Universitätsklinikum des Saarlandes

Homburg/Saar, , Germany

Site Status

Universitätsklinikum Leipzig

Leipzig, , Germany

Site Status

UKSH Campus Lübeck - Department for Anesthesiology and Intensive Care Medicine

Lübeck, , Germany

Site Status

University Hospital Magdeburg - Department for Anesthesiology and Intensive Care Medicine

Magdeburg, , Germany

Site Status

Universitätsklinikum Marburg

Marburg, , Germany

Site Status

Technische Universität München

München, , Germany

Site Status

Oberschwabenklinik Ravensburg Klinik für Anästhesie-, Intensiv-, Notfall- und Schmerzmedizin

Ravensburg, , Germany

Site Status

University Hospital Tübingen - Department for Anesthesiology and Intensive Care Medicine

Tübingen, , Germany

Site Status

Universitätsklinikum Ulm

Ulm, , Germany

Site Status

Universitätsklinikum Würzburg Klinik und Poliklinik für Anästhesiologie, Intensivmedizin und Schmerztherapie

Würzburg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Magunia H, Lederer S, Verbuecheln R, Gilot BJ, Koeppen M, Haeberle HA, Mirakaj V, Hofmann P, Marx G, Bickenbach J, Nohe B, Lay M, Spies C, Edel A, Schiefenhovel F, Rahmel T, Putensen C, Sellmann T, Koch T, Brandenburger T, Kindgen-Milles D, Brenner T, Berger M, Zacharowski K, Adam E, Posch M, Moerer O, Scheer CS, Sedding D, Weigand MA, Fichtner F, Nau C, Pratsch F, Wiesmann T, Koch C, Schneider G, Lahmer T, Straub A, Meiser A, Weiss M, Jungwirth B, Wappler F, Meybohm P, Herrmann J, Malek N, Kohlbacher O, Biergans S, Rosenberger P. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort. Crit Care. 2021 Aug 17;25(1):295. doi: 10.1186/s13054-021-03720-4.

Reference Type DERIVED
PMID: 34404458 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DCIR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.